- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pharma firms slapped USD 360 million fine after steroid price hikes over 10000 percent
CMA has fined Actavis UK, Auden Mckenzie, Allergan, Accord Healthcare, Intas, Waymade Plc, Amdipharm, Advanz Pharma and some entities of private-equity group Cinven.
Britain: Britain's competition regulator has fined more than 10 drug firms a record combined 260 million pounds ($360 million) for overcharging the National Health Service (NHS) for a steroid which rose from 70p to 88 pounds a pack in under eight years.
The Competition and Markets Authority (CMA) said on Thursday that the breaches meant the NHS paid over 10,000% more for single packs of 10 mg and 20 mg hydrocortisone tablets in 2016 than they were paying in 2008.
Hydrocortisone is used to treat conditions where adrenal glands do not make sufficient hormones, including the life-threatening Addison's disease.
The CMA said companies including Actavis, and its former parent and now Abbvie-owned Allergan, broke competition rules.
The companies engaged in practices including buying potential rivals to keep their versions off the market, increasing the price of hydrocortisone as sole providers, and continued to pay off the competition over the years, the CMA said.
"These are without doubt some of the most serious abuses we have uncovered in recent years," said CMA head Andrea Coscelli. "Our fine serves as a warning to any other drug firm planning to exploit the NHS."
Three of the more than 10 companies named in CMA's statement, Waymade, Accord, and Advanz, said they disagreed with the regulator's decision and told Reuters via email that they would appeal against the fine.
CMA has fined Actavis UK, Auden Mckenzie, Allergan, Accord Healthcare, Intas, Waymade Plc, Amdipharm, Advanz Pharma and some entities of private-equity group Cinven. Auden and Actavis UK together will pay 221.1 million pounds.
The other firms did not immediately respond to requests for comment.
CMA also said that in addition to its fines, the NHS would be able to seek damages.
Before April 2008, NHS was spending about 500,000 pounds annually on hydrocortisone tablets, the CMA said, adding that costs had risen to more than 80 million pounds by 2016.
Read also: Tribunal rejects pharma firms plea seeking to review order to recover Rs 1.55 crore penalty
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751